Диссертация (1140798), страница 23
Текст из файла (страница 23)
– 2014. – Vol. 192, № 2. – P.385-390.75.Huang, J. Clinical evaluation of prostate cancer gene 3 score in diagnosis amongChinese men with prostate cancer and benign prostatic hyperplasia / J. Huang //BMC Urol. – 2015. – Vol. 15 – P. 118.76.Imani, F.Intrarectal Lidocaine-Diltiazem-Meperidine Gel for TransrectalUltrasound Guided Prostate Biopsy / F. Imani // Anesthesiol. Pain Med. – 2015.
–Vol. 5, № 3. – P. 22568.77.Issa, M.M.A randomized prospective trial of intrarectal lidocaine for paincontrol during transrectal prostate biopsy: the Emory University experience /M.M. Issa // Eur. Urol. – 2000. – Vol. 164, № 2. – P. 397-399.78.Izol, V. Three different techniques for administering analgesia during transrectalultrasound-guided prostate biopsy: a comparative study / V.
Izol // Int. Braz. J.Urol. – 2012. – Vol. 38, № 1. – P. 122-128.79.Jelidi, A. Prostate cancer diagnosis: Efficacy of a simple electromagnetic MRITRUS fusion method to target biopsies / A. Jelidi // Eur. J. Radiol. – 2017. – Vol.86. – P. 127-134.80.Jiang, X.Magnetic resonance imaging-ultrasound fusion targeted biopsyoutperforms standard approaches in detecting prostate cancer: A meta-analysis /X. Jiang // Mol. Clin. Oncol. – 2016. – Vol. 5, № 2. – P. 301-309.81.Jones, J.S.
Prostate Cancer Diagnosis: PSA, Biopsy and Beyond / J.S. Jones. –Springer Science & Business Media, 2012.13782.Jones, J.S. Saturation prostate biopsy with periprostatic block can be performedin office / J.S. Jones, M. Oder, C.D. Zippe // Eur. Urol. – 2002. – Vol. 168, № 5.– P. 2108-2110.83.Kaplan, I. Real time MRI-ultrasound image guided stereotactic prostate biopsy /I. Kaplan // Magn. Res. Imag. – 2002. – Vol. 20, № 3. – P.
295-299.84.Kim, J. Focal lesion at the midline of the prostate on transrectal ultrasonography:take it or leave it? / J. Kim // Ultrasonography. – 2016. – Vol. 36, № 1. – P. 1016.85.Kim, S.Y. Pre-operative prediction of advanced prostatic cancer using clinicaldecision support systems: accuracy comparison between support vector machineand artificial neural network / S.Y. Kim // Korean J.
Radiol. – 2011. – Vol. 12, №5. – P. 588-594.86.Klemann, N.Antibiotic prophylaxis and complications following prostatebiopsies-a systematic review / N. Klemann // Danish Med. J. – 2017. – Vol. 64,№ 1. – P. 5323.87.Kopp, R.P. Preparation for Prostate Biopsy / R.P. Kopp, C.J. Kane, J.K. Parsons// Prostate Cancer Diagnosis. – Humana Press, 2013. – P. 121-131.88.Labanaris, A.P.
Prostate cancer detection using an extended prostate biopsyschema in combination with additional targeted cores from suspicious images inconventional and functional endorectal magnetic resonance imaging of theprostate / A.P. Labanaris // Prostate cancer and prostatic diseases. – 2010. – Vol.13, № 1. – P. 65-70.89.Lacetera, V. MRI/US fusion prostate biopsy: Our initial experience / V.
Lacetera// Archiv. Ital. Urol. Androl. – 2016. – Vol. 88, № 4. – P. 296-299.90.Lavallée, L.T. Trends in prostate biopsy in Ontario, 1992-2014: a cohort study /L.T. Lavallée // CMAJ Open. – 2016. – Vol. 4, № 4. – P. E698.91.Lawrentschuk, N. Predicting prostate biopsy outcome: artificial neural networksand polychotomous regression are equivalent models / N.
Lawrentschuk // Int.Urol. Nephrol. – 2011. – Vol. 43, № 1. – P. 23-30.13892.Le, J.D. Targeted prostate biopsy: value of multiparametric magnetic resonanceimaging in detection of localized cancer / J.D. Le // Asian J. Androl. – 2014. –Vol. 16, № 4. – P. 522.93.Lee, D.H. Can Western based online prostate cancer risk calculators be used topredict prostate cancer after prostate biopsy for the Korean population? / D.H.Lee // Yonsei Med.
J. – 2013. – Vol. 54, № 3. – P. 665-671.94.Lee, H.J. Role of Transrectal Ultrasonography in the Prediction of ProstateCancer Artificial Neural Network Analysis / H.J. Lee // J. Ultrasound Med. –2006. – Vol. 25, № 7. – P. 815-821.95.Lee, M.C. Multifocal high grade prostatic intraepithelial neoplasia is a risk factorfor subsequent prostate cancer / M.C. Lee // Eur. Urol. – 2010. – Vol. 184, № 5.– P. 1958-1962.96.Leinonen, J.
Signifiance of free and bound prostate-specific antigen / J. Leinonen,U.H. Stenman // Endocrine Rel. Cancer. – 1996. – Vol. 3, № 3. – P. 191-197.97.Li, M. Local anesthesia for transrectal ultrasound-guided biopsy of the prostate:A meta-analysis / M. Li // Sci. Rep. – 2017. – Vol. 7, № 1. – P. 40421.98.Liang, Y. Prostate cancer risk prediction in a urology clinic in Mexico / Y.
Liang// Urol. Oncol. – 2013. – Vol. 31, № 7. – P. 1085-1092.99.Liang, Y. The risk of biopsy-detectable prostate cancer using the prostate cancerprevention Trial Risk Calculator in a community setting / Y. Liang // Urol. Oncol.– 2013. – Vol. 31, № 8. – P. 1464-1469.100.Loeb, S. Overdiagnosis and overtreatment of prostate cancer / S. Loeb //Eur. Urol. – 2014. – Vol. 65, № 6.
– P. 1046-1055.101.Loeb, S. Systematic review of complications of prostate biopsy / S. Loeb //Eur. Urol. – 2013. – Vol. 64, № 6. – P. 876-892.102.Logan, J.K.Current status of MRI and ultrasound fusion softwareplatforms for guidance of prostate biopsies / J.K. Logan // BJU Int. – 2013. – Vol.10, № 5. - P. 641–652.139103.Luscombe, C.J. Pain during prostate biopsy / C.J. Luscombe, P.W.
Cooke //Lancet. – 2004. – N 363 (9424). – P. 1840-1841.104.Lynn, N.N.K. Periprostatic nerve block gives better analgesia for prostaticbiopsy / N.N.K. Lynn // BJU Int. – 2002. – Vol. 90, № 4. – P. 424-426.105.Mallick, S. Local anesthesia before transrectal ultrasound guided prostatebiopsy: comparison of 2 methods in a prospective, randomized clinical trial / S.Mallick // Eur. Urol. – – 2004. – Vol. 171, № 2. – P. 730-733.106.Manikandan, R.Nitrous oxide vs periprostatic nerve block with 1%lidocaine during transrectal ultrasound guided biopsy of the prostate: aprospective, randomized, controlled trial / R. Manikandan // Eur.
Urol. – 2003. –Vol. 170, № 5. – P. 1881-1883.107.Marks, L. MRI–ultrasound fusion for guidance of targeted prostate biopsy /L. Marks, S. Young, S. Natarajan // Curr. Opin. Urol. – 2013. – Vol. 23, № 1. –P. 43.108.Masood, J. Nitrous oxide (Entonox) inhalation and tolerance of transrectalultrasound guided prostate biopsy: a double-blind randomized controlled study /J. Masood // Eur. Urol. – 2002. – Vol.
168, № 1. – P. 116-120.109.Maxeiner, A.Added Value of Multiparametric Ultrasonography inMagnetic Resonance Imaging and Ultrasonography Fusion–guided Biopsy of theProstate in Patients With Suspicion for Prostate Cancer / A. Maxeiner // Urology.– 2015. – Vol. 86, № 1. – P. 108-114.110.Meng, M.V. The utility of apical anterior horn biopsies in prostate cancerdetection / M.V. Meng // Urol. Oncol. – 2003. – Vol. 21, № 5. – P. 361-365.111.Merola, R. PCA3 in prostate cancer and tumor aggressiveness detection on407 high-risk patients: a National Cancer Institute experience / R. Merola // J ExpClin Cancer Res.
– 2015. – Vol. 34. – P. 15.112.Moore, C.M.Image-guided prostate biopsy using magnetic resonanceimaging–derived targets: a systematic review / C.M. Moore // Eur. Urol. – 2013.– Vol. 63, № 1. – P. 125-140.140113.Murphy, D.G. The Melbourne Consensus Statement on the early detectionof prostate cancer / D.G.
Murphy // BJU Int. – 2014. – Vol. 113, № 2. – P. 186188.114.Murphy, I.G. MRI-directed cognitive fusion-guided biopsy of the anteriorprostate tumors / D.G. Murphy // Diagn. Intervent. Radiol. – 2017. - № 1. – P. 8793.115.Murray, K.S. A prospective study of erectile function after transrectalultrasonography‐guided prostate biopsy / K.S.
Murray // BJU Int. – 2015. – Vol.116, № 2. – P. 190-195.116.Nash, P.A. Transrectal ultrasound guided prostatic nerve blockade easessystematic needle biopsy of the prostate / P.A. Nash // Eur. Urol. – 1996. – Vol.155, № 2. – P.
607-609.117.NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer,Version3.2016:[Электронныйhttps://www.nccn.org/professionals/ресурс].URL:physician_gls/pdf/prostate.pdf(датаобращения: 04.01.2017).118.NCCN Clinical Practice Guidelines in Oncology on Prostate Cancer EarlyDetection, Version 2.2016: [Электронный ресурс].
URL: https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf(датаобращения:04.01.2017).119.Nguyen, C.T. Formalized prediction of clinically significant prostatecancer: is it possible? / C.T. Nguyen, M.W. Kattan // Asian J Androl. – 2012. –Vol. 14, № 3. – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
